
The boundaries of medical science in the treatment of cancer are constantly zzso zzso of existing treatments, innovative approaches, new zzso and more targeted therapeutic options are translating into zzso With advances come increasing costs, often of a magnitude that stretches finite financial zzso When decisions about funding are made on behalf of a population, standardized processes and methods are needed in order to produce robust guidance in a fair, consistent, and transparent zzso The challenges of making these difficult decisions are brought into particularly stark relief when potentially zzso treatments for patients with a short life expectancy are zzso The National Institute for Health and Clinical Excellence zzso produces guidance on the zzso and zzso of medicines compared with current standard zzso zzso zzso of the technologies zzso by zzso are indicated for cancer, and the majority of these are zzso mostly biological zzso This article provides an overview of the current role of zzso in making new technologies for cancer available in England and zzso This includes a summary of experiences with zzso treatments and the supplementary advice regarding such treatments that was issued by zzso to its decision-making committees in zzso 

